CNR Institutional Research Information System

MELILLO, ROSA MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.313
NA - Nord America 697
EU - Europa 323
SA - Sud America 265
AF - Africa 20
OC - Oceania 4
Totale 2.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 647
SG - Singapore 583
CN - Cina 296
BR - Brasile 227
VN - Vietnam 142
HK - Hong Kong 129
NL - Olanda 86
FR - Francia 81
IT - Italia 50
KR - Corea 44
DE - Germania 28
JP - Giappone 25
MX - Messico 20
FI - Finlandia 18
IN - India 18
AR - Argentina 17
GB - Regno Unito 17
CA - Canada 16
BD - Bangladesh 15
IQ - Iraq 10
EC - Ecuador 8
ID - Indonesia 8
UA - Ucraina 7
ZA - Sudafrica 7
IL - Israele 6
PK - Pakistan 6
ES - Italia 5
RU - Federazione Russa 5
AT - Austria 4
HU - Ungheria 4
KZ - Kazakistan 4
TR - Turchia 4
UZ - Uzbekistan 4
CR - Costa Rica 3
EG - Egitto 3
IE - Irlanda 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PE - Perù 3
PL - Polonia 3
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
GU - Guam 1
HN - Honduras 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.622
Salva come PNG Salva come JPEG
Città #
Singapore 330
Santa Clara 291
Hong Kong 129
Hefei 90
Beijing 81
Lauterbourg 64
San Jose 59
Ho Chi Minh City 48
Seoul 44
Ashburn 36
Hanoi 33
Los Angeles 23
Tokyo 18
Dallas 16
São Paulo 15
Helsinki 13
New York 13
Da Nang 11
Buffalo 10
Rome 9
Naples 8
Frankfurt am Main 7
Minamishinagawa 7
Baghdad 6
Belo Horizonte 6
Düsseldorf 6
Rio de Janeiro 6
Atlanta 5
Brasília 5
Dhaka 5
Haiphong 5
Johannesburg 5
London 5
Uberlândia 5
Brooklyn 4
Chennai 4
Denver 4
Falkenstein 4
Florence 4
Kyiv 4
Mexico City 4
Montreal 4
Munich 4
Ribeirão Preto 4
Salerno 4
Santo André 4
Tashkent 4
Turku 4
Vienna 4
Biên Hòa 3
Blumenau 3
Buenos Aires 3
Campinas 3
Council Bluffs 3
Curitiba 3
Dublin 3
Guayaquil 3
Hangzhou 3
Hải Dương 3
Indaiatuba 3
Las Vegas 3
Madrid 3
Manchester 3
Osasco 3
Paris 3
Poplar 3
Porto Alegre 3
Querétaro 3
San José 3
Acalanes Ridge 2
Almaty 2
Andorinha 2
Ankara 2
Barra do Piraí 2
Bengaluru 2
Boardman 2
Boston 2
Cabo Frio 2
Cairo 2
Cariacica 2
Caruaru 2
Chapecó 2
Chicago 2
Cleveland 2
Concord 2
Córdoba 2
Duque de Caxias 2
Elk Grove Village 2
Goiânia 2
Houston 2
Joinville 2
José C. Paz 2
Karachi 2
Karbala 2
Lahore 2
Manaus 2
Marseille 2
Milan 2
Nuremberg 2
Orem 2
Totale 1.596
Salva come PNG Salva come JPEG
Nome #
Indoleamine 2,3-Dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment 81
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 76
Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines 72
Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies 59
Genetic alterations in differentiated thyroid cancer: what can be expected for gene expression profiling of thyroid carcinomas 58
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. 56
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents 56
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer 53
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). 49
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 48
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 48
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway. 48
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth 47
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma 46
Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells 45
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 45
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. 44
Ret-mediated mitogenesis requires Src kinase activity 43
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. 43
AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer 43
Genetics: The genomic landscape of papillary thyroid carcinoma 42
AXL is an oncotarget in human colorectal cancer 42
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. 42
New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution 41
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 40
Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. 40
Role of Formyl Peptide Receptors In Gastrointestinal Healing. 40
RET/PTC activation in human thyroid carcinomas 40
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 39
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. 39
BRAF is a therapeutic target in aggressive thyroid carcinoma. 38
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. 37
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. 36
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2). 35
Multiple anti-tumor effects of Reparixin on thyroid cancer 34
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 34
The RET receptor family 34
L'osteopontina: un nuovo marcatore biologico dei carcinomi della testa e del collo 33
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways 33
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. 33
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 33
Biochemical and molecular characterization of the novel BRAF V599Ins mutation detected in a classic papillary thyroid carcinoma 32
Inflammation in thyroid oncogenesis. 31
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 31
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. 31
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. 30
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 30
Mast cells have a protumorigenic role in human thyroid cancer. 30
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas. 29
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture 29
Minireview: RET: normal and abnormal functions 28
Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer 28
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. 28
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes 27
Molecular biomarkers in thyroid FNA samples 27
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. 27
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 25
The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 25
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 25
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma. 25
Activation of the Erk8 MAP kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene 24
Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): Evidence for a divergence of the ERKs and JNKs pathways induced by Ret 24
Glial cell line-Derived Neurotrophic Factor differentially stimulates Ret mutants associated with the Multiple Endocrine Neoplasia type 2 syndromes and Hirschsprung's disease 24
Different mutations of the RET gene cause different human tumoral diseases 24
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenic mechanism of multiple endocrine neoplasia type 2B 24
RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. 23
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation 23
Dysfunction of the RET receptor in human cancer. 22
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension 22
Molecular biology of the MEN2 gene 22
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. 20
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters. 17
Totale 2.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.436
article - articoli 8.188
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 148
Totale 16.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 2 0 9 1
2024/20251.156 3 3 66 44 271 47 16 79 39 103 262 223
2025/20261.484 80 144 160 243 310 51 195 62 93 99 47 0
Totale 2.652